Luciana Borio

Luciana Borio

Director/Board Member at EAGLE PHARMACEUTICALS, INC.

Net worth: 390 449 $ as of 2024-03-30

53 year
Finance
Health Technology
Consumer Services

Profile

Luciana Borio, M.D., is a Venture Partner at ARCH Venture Partners.
In this capacity, she advises on and helps develop new investment opportunities related to biologics manufacturing, clinical trials, novel therapies and areas with large unmet clinical needs.
Dr. Borio is a specialist in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies.
Prior to joining ARCH, she was a senior vice president at In-Q-Tel, an independent, non-profit, strategic investment firm that works to deliver innovative technology solutions to support the missions of the U.S.
Intelligence Community.
Past positions include serving as a member of President Biden’s transition COVID-19 Advisory Board and Director for Medical and Biodefense Preparedness at the National Security Council (2017-2019), where she coordinated the response to the Ebola epidemic in West Africa, efforts to combat antimicrobial resistance, and the development of an Executive Order to modernize America’s influenza vaccines.
Prior to that, she was the Acting Chief Scientist of the U.S.
Food and Drug Administration (2015-2017) and the Assistant Commissioner for Counterterrorism Policy of the FDA (2010-2017).
Dr. Borio is an adjunct Assistant Professor of Medicine at Johns Hopkins University (2003-present), where she continues to practice medicine part-time.
She is also a senior fellow for global health at the Council on Foreign Relations.
Dr. Borio obtained her M.D.
from George Washington University, completed a residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center, and a combined fellowship in infectious diseases at Johns Hopkins and critical care at the National Institutes of Health.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-12-14 2,278 ( 0.00% ) 390 449 $ 2024-03-30
2023-03-30 0 ( -.--% ) - $ 2024-03-30

Luciana Borio active positions

CompaniesPositionStart
EAGLE PHARMACEUTICALS, INC. Director/Board Member 2021-04-27
INSULET CORPORATION Director/Board Member 2021-10-17
Director/Board Member 2021-10-24
Private Equity Investor 2021-11-30
Director/Board Member -
All active positions of Luciana Borio

Former positions of Luciana Borio

CompaniesPositionEnd
Corporate Officer/Principal 2019-12-31
National Security Council Corporate Officer/Principal 2018-12-31
Corporate Officer/Principal 2016-12-31
Corporate Officer/Principal 2008-09-30
See the detail of Luciana Borio's experience

Training of Luciana Borio

George Washington University Undergraduate Degree
George Washington University School of Medicine & Health Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Luciana Borio's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
EAGLE PHARMACEUTICALS, INC.

Health Technology

INSULET CORPORATION

Health Technology

Private companies7

Finance

Commercial Services

Government

Finance

National Security Council

Technology Services

Commercial Services

See company connections